Answers are grounded in this paper and cite their sources.
, resistance to fosfomycin increased significantly from 45.6% to 76.6%. Fosfomycin treatment of urinary tract infections showed an excellent seven-day clinical efficacy (79.7%). However, when used to treat recurrent or complicated urinary tract infections, fosfomycin treatment was associated with high levels of infection relapse, leading to relapse in a total of 20.4% of patients during the first two months. This indicates that fosfomycin exhibits good efficacy only for the treatment of uncomplicated urinary tract infections.
No takes yet. Share an insight, caveat, or question.
Fajfr et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: